NTRB · NASDAQ · Biotechnology

Nutriband

Develops transdermal drug products centered on its AVERSA abuse-deterrent patch technology.

$4.46
After-hours close−0.01 (−0.22%)
At close$4.47(−3.25%)
DateEstimateReportedSurprise
Sep 2026
Jun 2026−$0.10
Jun 2026
Apr 2026−$1.89−$0.04+97.9%
Dec 2025−$2.13−$0.12+94.4%
Sep 2025−$0.17−$2.12−1,147.1%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
May 2025
Apr 2025
Dec 2024
Sep 2024
May 2024
Apr 2024
Dec 2023
Sep 2023
Jun 2023
Apr 2023
Dec 2022
Sep 2022
May 2022
Apr 2022
Dec 2021
Sep 2021
Jun 2021
Apr 2021
Dec 2020
Sep 2020
Jun 2020
Apr 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
Dec 2018
Sep 2018
Jun 2018
May 2018
Dec 2017
Sep 2017
Jun 2017
May 2017
Dec 2016
Sep 2016
Apr 2016
Jan 2016
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Sep 30, 2026
Jun 11, 2026−$0.10$433.4K
Jun 5, 2026
Apr 29, 2026−$1.89−$0.04+97.9%$765.0K$765.0K0.0%
Dec 16, 2025−$2.13−$0.12+94.4%$675.0K$346.1K−48.7%
Sep 9, 2025−$0.17−$2.12−1,147.1%$675.0K$622.5K−7.8%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
May 30, 2025
Apr 28, 2025
Dec 3, 2024
Sep 3, 2024
May 31, 2024
Apr 30, 2024
Dec 12, 2023
Sep 11, 2023
Jun 9, 2023
Apr 26, 2023
Dec 2, 2022
Sep 7, 2022
May 31, 2022
Apr 29, 2022
Dec 14, 2021
Sep 3, 2021
Jun 14, 2021
Apr 2, 2021
Dec 15, 2020
Sep 11, 2020
Jun 4, 2020
Apr 14, 2020
Dec 13, 2019
Sep 13, 2019
Jun 14, 2019
Apr 20, 2019
Dec 14, 2018
Sep 17, 2018
Jun 18, 2018
May 1, 2018
Dec 8, 2017
Sep 19, 2017
Jun 19, 2017
May 5, 2017
Dec 13, 2016
Sep 14, 2016
Apr 30, 2016
Jan 31, 2016